The Conjugated Bile Acids Profile Suggests a Novel Liver‐Muscle Axis Associated With Sarcopenia in Chronic Liver Disease
Liver International · 2026
DOI: 10.1111/liv.70612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Motoh Iwasa und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Japan. Hauptthemen laut MEDLINE: Sarcopenia, Bile Acids and Salts, Liver, Liver Cirrhosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, National Center of Neurology and Psychiatry.
Abstract (Originalsprache)
Background
Liver‐related sarcopenia is a devastating systemic complication of chronic liver disease (CLD) driven by mechanisms extending beyond nutritional deficiency. However, the role of liver‐derived humoral factors remains unclear. We utilised a unique cohort of human skeletal muscle biopsies to test the hypothesis that serum conjugated bile acids (C‐BAs) act as key mediators of this liver‐muscle cross‐talk.
Methods
Serum and rectus abdominis muscle samples were meticulously collected from 36 CLD patients and 6 non‐CLD controls during elective surgery. Multifidus‐erector spinae and psoas muscle areas were quantified from CT images. Comprehensive correlations were analysed between C‐BAs and molecular markers of muscle inflammation and fibre‐type composition. These findings were supplemented by in vitro validation using GCDCA treatment of C2C12 myotubes.
Results
Serum C‐BAs levels were significantly elevated in CLD patients. The liver cirrhosis (LC) group exhibited a significantly smaller multifidus‐erector spinae area (32.06 ± 8.05 cm 2 ) compared to controls (39.78 ± 4.38 cm 2 , p = 0.019). Muscle area loss was strongly correlated with hepatic reserve deterioration (ALBI/ALB) and systemic inflammation (serum IL‐6). Crucially, muscle area was negatively correlated with the ratio of tauro‐C‐BAs ( p < 0.05). Muscle biopsies showed a molecular shift: enrichment of the slow‐twitch fibre marker myosin‐heavy chain 7 (MYH7, type I) and a concomitant reduction of the fast‐twitch marker MYH4 (type IIb), alongside signs of local chronic inflammation ( p < 0.05). The reduction in MYH4 was correlated with glyco‐C‐BAs, a finding replicated in GCDCA‐treated C2C12 myotubes.
Conclusions
Elevated C‐BAs may represent a critical, liver‐derived humoral factor associated with the pathological features of liver‐related sarcopenia. C‐BA‐associated muscle mass loss and systemic inflammation are reflected at the molecular level by a shift toward a slow‐twitch phenotype, accumulation of macrophages and altered energy metabolism in muscle biopsies. These findings suggest that C‐BAs may serve as a potentially actionable therapeutic target for mitigating muscle catabolism and improving clinical outcomes in CLD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Japan.
- Department of Gastroenterology, Murase Hospital, Suzuka, Japan.
- Biobank Center, Mie University Hospital, Tsu, Japan.
- Department of Gastroenterology, Clinical Research Institute, NHO Kyushu Medical Center, Fukuoka, Japan.
- Joint Research Center, Tokyo Medical University, Ibaraki Medical Center, Inashiki-gun, Japan.
- Department of Laboratory Animal Medicine, Tohoku University School of Medicine, Sendai, Japan.
ORCID-Profile: Akiko Eguchi, Motoyuki Kohjima, Teruo Miyazaki, Yoshinao Kobayashi, Akira Honda, Hayato Nakagawa, Tadashi Ikegami, Aldo J Montano-Loza
Förderung
- Japan Society for the Promotion of Science
- National Center of Neurology and Psychiatry
Zitieren
APA
Iwasa, M., Eguchi, A., Kohjima, M., Miyazaki, T., Kitamura, H., Takami, Y., Yamashita, N., Tempaku, M., Izuoka, K., Kobayashi, Y., Takei, Y., Honda, A., Nakagawa, H., Ikegami, T., Nakamuta, M., Okabe, J., & Montano-Loza, A. J. (2026). The Conjugated Bile Acids Profile Suggests a Novel Liver‐Muscle Axis Associated With Sarcopenia in Chronic Liver Disease. Liver International. https://doi.org/10.1111/liv.70612
Vancouver
Iwasa M, Eguchi A, Kohjima M, Miyazaki T, Kitamura H, Takami Y, et al. The Conjugated Bile Acids Profile Suggests a Novel Liver‐Muscle Axis Associated With Sarcopenia in Chronic Liver Disease. Liver International. 2026. doi:10.1111/liv.70612
BibTeX
@article{Iwasa2026,
author = {Iwasa, Motoh and Eguchi, Akiko and Kohjima, Motoyuki and Miyazaki, Teruo and Kitamura, Hiroshi and Takami, Yuko and Yamashita, Naoki and Tempaku, Mina and Izuoka, Kiyora and Kobayashi, Yoshinao and Takei, Yoshiyuki and Honda, Akira and Nakagawa, Hayato and Ikegami, Tadashi and Nakamuta, Makoto and Okabe, Jun and Montano-Loza, Aldo J},
title = {The Conjugated Bile Acids Profile Suggests a Novel Liver‐Muscle Axis Associated With Sarcopenia in Chronic Liver Disease},
journal = {Liver International},
year = {2026},
doi = {10.1111/liv.70612}
}
EUVIMED